AbbVie (NYSE:ABBV) is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of ...

AbbVie recently announced the availability of its drug SKYRIZI® in Canada for treating adults with ulcerative colitis, building on Health Canada's prior approval. This significant development may ...

AbbVie recently announced the availability of its drug SKYRIZI® in Canada for treating adults with ulcerative colitis, building on Health Canada's prior approval. This significant development may ...

AbbVie (NYSE:ABBV) and Calibr today announced an expanded strategic collaboration to advance several innovative preclinical and... AbbVie (NYSE:ABBV) today announced the British Journal of ...

Immunogen (IMGN) to Resume Trading at 8 a.m. Following News of Takeover by AbbVie (ABBV) Earlier: AbbVie Inc (NYSE:ABBV).

(RTTNews) - AbbVie Inc. (ABBV) Tuesday said that its Skyrizi approved for the treatment of adults with moderately to severely active ulcerative colitis is now available in Canada. Ulcerative ...

REITs pay dividends out of their funds from operations (FFO), and Vici's FFO per share is $2.61 over the last 12 months. This ...

Defensive stocks, bonds, and gold are essential in an all-weather portfolio to navigate the Trump era's economic ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE ... tariffs for automakers meeting the United States-Mexico-Canada Agreement (USMCA) requirements. The news sparked ...

A treat-to-target study of upadacitinib in atopic dermatitis showed that dosing can be adjusted depending on early patient ...